Muvalaplin shows promise in lowering Lp(a) levels in clinical trial

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the American Heart Association’s Scientific Sessions 2024.

U.S. Tuberculosis Cases Reach Highest Level in a Decade

The number of U.S. tuberculosis (TB) cases in 2023 were the highest in a decade, a CDC report showed. Forty states reported an increase in

March 30, 2024

Natural compound in turmeric may be as effective as omeprazole for treating indigestion

A natural compound found in the culinary spice turmeric may be as effective as omeprazole-; a drug used to curb excess stomach acid-; for treating

September 12, 2023

Revolutionary self-folding nanoscale MRI agent sharpens cancer imaging

Study introduces a novel self-folding nanoscale contrast agent for MRI, enhancing tumor visualization with lower gadolinium loads and reduced risk of adverse effects.

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.